Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer

NCT00054626 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

700

Enrollment

OTHER_GOV

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: cisplatin
DRUG: gemcitabine hydrochloride
PROCEDURE: adjuvant therapy

Sponsor

Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy